2008
DOI: 10.1016/j.pharmthera.2008.07.005
|View full text |Cite
|
Sign up to set email alerts
|

Constitutive activation of G protein-coupled receptors and diseases: Insights into mechanisms of activation and therapeutics

Abstract: The existence of constitutive activity for G protein-coupled receptors (GPCRs) was first described in 1980s. In 1991, the first naturally occurring constitutively active mutations in GPCRs that cause diseases were reported in rhodopsin. Since then, numerous constitutively active mutations that cause human diseases were reported in several additional receptors. More recently, loss of constitutive activity was postulated to also cause diseases. Animal models expressing some of these mutants confirmed the roles o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
108
1
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 146 publications
(113 citation statements)
references
References 332 publications
(348 reference statements)
2
108
1
2
Order By: Relevance
“…However, in this study, alanine mutation of D178 3.49 A and Y189 3.60 A had no effect on the basal activity of MC3R, implying that such hydrogen bonding interactions do not exist or do not affect the basal activity of MC3R. There is usually a correlation between the basal activity of the WT receptor and the propensity of mutations to be constitutively active (Tao et al 2002, Tao 2008. As MC3R basal activity is low, the propensity of MC3R mutations to be constitutively active is probably low.…”
Section: Discussioncontrasting
confidence: 52%
“…However, in this study, alanine mutation of D178 3.49 A and Y189 3.60 A had no effect on the basal activity of MC3R, implying that such hydrogen bonding interactions do not exist or do not affect the basal activity of MC3R. There is usually a correlation between the basal activity of the WT receptor and the propensity of mutations to be constitutively active (Tao et al 2002, Tao 2008. As MC3R basal activity is low, the propensity of MC3R mutations to be constitutively active is probably low.…”
Section: Discussioncontrasting
confidence: 52%
“…So-called "constitutively activating" mutations and their gene products contribute to a broad range of clinical conditions ranging from cancer to syndromic developmental defects, including inborn disorders of metabolism, endocrine abnormalities, and sensory defects (1)(2)(3). Constitutively activating mutations, commonly referred to as "gain-offunction" mutations, can augment function in multiple ways.…”
mentioning
confidence: 99%
“…Two SDMs (L140G and L140R) had similar levels of ERK1/2 phosphorylation as that of WT MC4R upon NDP-MSH stimulation, different from their cAMP signaling properties. It is interesting to note that although L140R had decreased basal cAMP activity (see also Tao (2008)), it had significant constitutive pERK1/2 levels (Fig. 11C).…”
Section: Signaling Properties Of L140 Mutants At the Erk1/2 Pathwaymentioning
confidence: 80%